Not Signed In -
Creatinine |
|
|
Chemical structure of creatinine. Creatinine is a breakdown product of creatine phosphate in muscle, and is usually produced at a fairly constant rate by the body (depending on muscle mass). Physiology It is mainly filtered by the kidney, though a small amount is actively secreted. There is some tubular reabsorption of creatinine, but this is compensated by a roughly equivalent degree of tubular secretion. If the filtering of the kidney is deficient, blood levels rise. This effect ...
Wikipedia - [full article]
Creatinine Clinical Trials
- Role of Acetylcysteine in Creatinine Clearance
ClinicalTrials.gov Identifier: NCT00396396 - Recruiting
Creatinine Clearance
- Validation of Serum Creatinine Dosage and Renal Clearance
ClinicalTrials.gov Identifier: NCT00323128 - Recruiting
Kidney Failure
- Urine Chloride/Creatinine Ratio for Estimation of Urine Sodium
ClinicalTrials.gov Identifier: NCT00324883 - Recruiting
Hypertension
- The Effect of Administration on N-Acetylcysteine on Serum Creatinine Levels in Patients With Chronic Kidney Disease
ClinicalTrials.gov Identifier: NCT00498342 - Recruiting
Chronic Kidney Disease
- Effect of N-Acetylcysteine on Creatinine in Chronic Kidney Disease
ClinicalTrials.gov Identifier: NCT00506506 - Not yet recruiting
Stage 3 Chronic Kidney Disease
- ARMOR (Analyzing Renal Mechanisms of Creatinine Excretion in Patients On tesaglitazaR)
ClinicalTrials.gov Identifier: NCT00229684 - Completed
Diabetes Mellitus, Type 2
- Impact of Polymorphisms of OAT1, OAT3 and OCT2 on Transportation of Potential Nephrotoxic Drugs
ClinicalTrials.gov Identifier: NCT00251017 - Not yet recruiting
Subjects 16 Years of Age or Older, of Either Sex.; Subjects Have a Medication Including Vancomycin
- MESNA for Prevention of Acute Deterioration of Renal Function Following Contrast Agent Application
ClinicalTrials.gov Identifier: NCT00223548 - Completed
Chronic Renal Insufficiency; Serum Creatinine Concentration; Contrast Media Exposition
- Clinical Trial of Creatine in Amyotrophic Lateral Sclerosis
ClinicalTrials.gov Identifier: NCT00005766 - Completed
Amyotrophic Lateral Sclerosis
- Mean Arterial Pressure (MAP) and Renal Perfusion: Evaluation of Critically Ill Patients with Normal Creatinine Or Reduced Renal Function
ClinicalTrials.gov Identifier: NCT00117416 - Suspended
Kidney Failure, Acute
- To Determine the Effects of Avosentan On Doubling of Serum Creatinine, End Stage Renal Disease and Death in Diabetic Nephropathy
ClinicalTrials.gov Identifier: NCT00120328 - Terminated
Diabetic Nephropathy
email this page
print this page
bookmark this page
feedback on this page
